Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

OBJECTIVE: To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-line platinum-based therapy. METHODS: This was an open-label, single-arm and multicenter clinical tr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Ovarian Res
Autori principali: Yuan, Zhen, Zhang, Ying, Cao, Dongyan, Shen, Keng, Li, Qingshui, Zhang, Guonan, Wu, Xiaohua, Cui, Manhua, Yue, Ying, Cheng, Wenjun, Wang, Li, Qu, Pengpeng, Tao, Guangshi, Hou, Jianqing, Sun, Lixin, Meng, Yuanguang, Li, Guiling, Li, Changzhong, Shi, Huirong, Chen, Yaqing
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7798203/
https://ncbi.nlm.nih.gov/pubmed/33423683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-020-00736-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi